本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corbus Pharmaceuticals Holdings, Inc.

9.71
-0.4300-4.24%
盤後9.710.00000.00%19:39 EDT
成交量:25.22萬
成交額:250.55萬
市值:1.72億
市盈率:-1.65
高:10.38
開:9.92
低:9.69
收:10.14
52周最高:20.56
52周最低:5.12
股本:1,773.65萬
流通股本:1,274.79萬
量比:1.06
換手率:1.98%
股息:- -
股息率:- -
每股收益(TTM):-5.9000
每股收益(LYR):-5.9000
淨資產收益率:-54.18%
總資產收益率:-32.91%
市淨率:1.17
市盈率(LYR):-1.65

資料載入中...

2022/04/11

重要事件披露

8-K - Current report
2022/03/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/08

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/08

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/03

重要事件披露

8-K - Current report
2021/12/08

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/12/08

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/24

重要事件披露

8-K - Current report
2021/06/17

重要事件披露

8-K - Current report
2021/06/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/01

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/16

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/15

重要事件披露

8-K - Current report